Tempus AI Inc. (NASDAQ:TEM) is one of the top 10 hidden AI stocks to buy. On May 31, Tempus AI launched the next generation of Lens, an agentic AI platform designed to accelerate oncology drug development. By integrating Tempus’ massive library of longitudinal real-world data, oncology foundation models, and computational infrastructure, the platform provides an […]
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
317last 24h
2132last 7d
379● bullish (7d)
183● bearish (7d)
204publishers
Insider Monkey37d agoneutral
Tempus AI (TEM) Launches Next-Gen Agentic Platform to Accelerate Oncology ResearchInsider Monkey80d agoneutral
Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology AlgorithmTrading with an implied upside of 60.5% and an RSI of 34.6, Tempus AI, Inc. (NASDAQ:TEM) has emerged as a notable oversold play in the AI sector. In a span of a week, Tempus AI, Inc. (NASDAQ:TEM) made two announcements that add to its growing pipeline of clinical and pharma partnerships. The freshest update came […]